| abstract |
Disclosed are: a method for measuring a sugar chain marker glycoprotein, which can detect a hepatic disease with higher accuracy compared to conventional methods; a method for detecting a hepatic disease, which can detect a hepatic disease with higher accuracy compared to conventional methods; a reagent for the quantification of a glycoprotein, which can be used in the measurement methods; and a sugar chain marker glycoprotein which is used as a measure of disease conditions of a hepatic disease and enables the distinction of the disease conditions of the hepatic disease depending on the progression of the hepatic disease. Specifically disclosed is a method for measuring at least one glycoprotein that is contained in a sample collected from a subject and is selected from alpha-1-acid glycoprotein(AGP) and Mac-2-binding protein(M2BP), wherein AGP bound to a first lectin selected from AOL and MAL is measured when the glycoprotein is AGP, and M2BP bound to a second lectin selected from WFA, BPL, AAL, RCA120 and TJAII is measured when the glycoprotein is M2BP. |